AAAAAA

   
Results: 1-9 |
Results: 9
Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue
Authors: Maeurer, MJ Necker, A Salter, RD Castelli, C Hohn, H Karbach, J Freitag, K Neukirch, C Knuth, A Jager, E
Citation: Mj. Maeurer et al., Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue, INT J CANC, 97(1), 2002, pp. 64-71
Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction
Authors: Ringhoffer, M Schmitt, M Karbach, J Jager, E Oesch, F Arand, M
Citation: M. Ringhoffer et al., Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction, INT J ONCOL, 19(5), 2001, pp. 983-989
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library
Authors: Jager, D Stockert, E Gure, AO Scanlan, MJ Karbach, J Jager, E Knuth, A Old, LJ Chen, YT
Citation: D. Jager et al., Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library, CANCER RES, 61(5), 2001, pp. 2055-2061
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
Authors: Jager, E Nagata, Y Gnjatic, S Wada, H Stockert, E Karbach, J Dunbar, PR Lee, SY Jungbluth, A Jager, D Arand, M Ritter, C Cerundolo, V Dupont, B Chen, YT Old, LJ Knuth, A
Citation: E. Jager et al., Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses, P NAS US, 97(9), 2000, pp. 4760-4765
Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers
Authors: Jager, E Gnjatic, S Nagata, Y Stockert, E Jager, D Karbach, J Neumann, A Rieckenberg, J Chen, YT Ritter, G Hoffman, E Arand, M Old, LJ Knuth, A
Citation: E. Jager et al., Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers, P NAS US, 97(22), 2000, pp. 12198-12203
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB40101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma
Authors: Jager, E Jager, D Karbach, J Chen, YT Ritter, G Nagata, Y Gnjatic, S Stockert, E Arand, M Old, LJ Knuth, A
Citation: E. Jager et al., Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB40101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma, J EXP MED, 191(4), 2000, pp. 625-630
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanomapatient responding to continued immunization with melanoma-associated peptides
Authors: Jager, E Maeurer, M Hohn, H Karbach, J Jager, D Zidianakis, Z Bakhshandeh-Bath, A Orth, J Neukirch, C Necker, A Reichert, TE Knuth, A
Citation: E. Jager et al., Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanomapatient responding to continued immunization with melanoma-associated peptides, INT J CANC, 86(4), 2000, pp. 538-547
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: Correlation with clinical events
Authors: Jager, E Stockert, E Zidianakis, Z Chen, YT Karbach, J Jager, D Arand, M Ritter, G Old, LJ Knuth, A
Citation: E. Jager et al., Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: Correlation with clinical events, INT J CANC, 84(5), 1999, pp. 506-510
Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A
Authors: Jager, E Hohn, H Karbach, J Momburg, F Castelli, C Knuth, A Seliger, B Maeurer, MJ
Citation: E. Jager et al., Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A, INT J CANC, 81(6), 1999, pp. 979-984
Risultati: 1-9 |